Physician profile
Patrick Kyle Evers
NPI 1942620596
$848.85
in general payments reported to CMS, 2019-2025
7 companies · $28.49 in 2025
The $28.49 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $561 · 2020: $94.72 · 2021: $143 · 2023: $21.79 · 2025: $28.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $434.92 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $178.61 | 2019 | |
| Boston Scientific Corporation | $147.93 | 2019-2021 | |
| Cvrx, INC. | $28.49 | 2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $21.79 | 2023 | Camzyos |
| Pfizer INC. | $18.56 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $18.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Evers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.